vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and Velo3D, Inc. (VELO). Click either name above to swap in a different company.
Azenta, Inc. is the larger business by last-quarter revenue ($148.6M vs $9.4M, roughly 15.7× Velo3D, Inc.). Azenta, Inc. runs the higher net margin — -10.4% vs -231.9%, a 221.6% gap on every dollar of revenue. On growth, Azenta, Inc. posted the faster year-over-year revenue change (0.8% vs -25.2%). Azenta, Inc. produced more free cash flow last quarter ($14.7M vs $-8.3M). Over the past eight quarters, Azenta, Inc.'s revenue compounded faster (4.4% CAGR vs -1.8%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Velo3D, Inc. develops and sells advanced end-to-end metal additive manufacturing (3D printing) solutions, comprising industrial-grade printers, specialized processing software, and high-performance metal materials. It primarily serves global aerospace, defense, energy, semiconductor and industrial manufacturing markets, enabling customers to produce complex, high-precision metal parts that are difficult to manufacture with traditional methods.
AZTA vs VELO — Head-to-Head
Income Statement — Q1 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $9.4M |
| Net Profit | $-15.4M | $-21.9M |
| Gross Margin | 42.9% | -73.6% |
| Operating Margin | -4.9% | -231.0% |
| Net Margin | -10.4% | -231.9% |
| Revenue YoY | 0.8% | -25.2% |
| Net Profit YoY | -15.7% | -2.9% |
| EPS (diluted) | $-0.34 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $9.4M | ||
| Q3 25 | $159.2M | $13.6M | ||
| Q2 25 | $143.9M | $13.6M | ||
| Q1 25 | $143.3M | $9.3M | ||
| Q4 24 | $147.4M | $12.6M | ||
| Q3 24 | $150.6M | $8.2M | ||
| Q2 24 | $144.3M | $10.3M | ||
| Q1 24 | $136.4M | $9.8M |
| Q4 25 | $-15.4M | $-21.9M | ||
| Q3 25 | $50.9M | $-11.2M | ||
| Q2 25 | $-48.0M | $-13.3M | ||
| Q1 25 | $-47.7M | $-25.0M | ||
| Q4 24 | $-11.0M | $-21.3M | ||
| Q3 24 | $-6.6M | $-21.9M | ||
| Q2 24 | $-6.6M | $935.0K | ||
| Q1 24 | $-137.4M | $-27.5M |
| Q4 25 | 42.9% | -73.6% | ||
| Q3 25 | 45.4% | 3.2% | ||
| Q2 25 | 46.2% | -11.7% | ||
| Q1 25 | 43.8% | 7.5% | ||
| Q4 24 | 46.7% | -3.5% | ||
| Q3 24 | 45.5% | 49.4% | ||
| Q2 24 | 44.8% | -28.0% | ||
| Q1 24 | 43.8% | -28.8% |
| Q4 25 | -4.9% | -231.0% | ||
| Q3 25 | 1.2% | -73.3% | ||
| Q2 25 | -1.3% | -85.4% | ||
| Q1 25 | -12.7% | -123.6% | ||
| Q4 24 | -5.9% | -167.0% | ||
| Q3 24 | -3.1% | -213.8% | ||
| Q2 24 | -4.9% | -187.7% | ||
| Q1 24 | -18.1% | -211.1% |
| Q4 25 | -10.4% | -231.9% | ||
| Q3 25 | 32.0% | -82.0% | ||
| Q2 25 | -33.4% | -97.7% | ||
| Q1 25 | -33.3% | -268.4% | ||
| Q4 24 | -7.5% | -168.5% | ||
| Q3 24 | -4.4% | -265.3% | ||
| Q2 24 | -4.5% | 9.0% | ||
| Q1 24 | -100.8% | -281.2% |
| Q4 25 | $-0.34 | $-0.87 | ||
| Q3 25 | $1.12 | $-0.65 | ||
| Q2 25 | $-1.05 | $-0.94 | ||
| Q1 25 | $-1.04 | $-1.87 | ||
| Q4 24 | $-0.25 | $7.06 | ||
| Q3 24 | $-0.25 | $-35.52 | ||
| Q2 24 | $-0.12 | $1.65 | ||
| Q1 24 | $-2.48 | $-55.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $39.0M |
| Total DebtLower is stronger | — | $31.0M |
| Stockholders' EquityBook value | $1.7B | $38.2M |
| Total Assets | $2.1B | $105.3M |
| Debt / EquityLower = less leverage | — | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $39.0M | ||
| Q3 25 | $279.8M | $11.8M | ||
| Q2 25 | $270.0M | $854.0K | ||
| Q1 25 | $253.6M | $3.9M | ||
| Q4 24 | $377.5M | $1.2M | ||
| Q3 24 | $280.0M | $1.6M | ||
| Q2 24 | $336.5M | $3.2M | ||
| Q1 24 | $353.5M | $10.9M |
| Q4 25 | — | $31.0M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | — | $22.5M | ||
| Q1 25 | — | $21.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $32.3M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $44.0M |
| Q4 25 | $1.7B | $38.2M | ||
| Q3 25 | $1.7B | $29.9M | ||
| Q2 25 | $1.7B | $21.4M | ||
| Q1 25 | $1.7B | $32.8M | ||
| Q4 24 | $1.7B | $39.7M | ||
| Q3 24 | $1.8B | $34.4M | ||
| Q2 24 | $2.0B | $52.1M | ||
| Q1 24 | $2.2B | $45.5M |
| Q4 25 | $2.1B | $105.3M | ||
| Q3 25 | $2.1B | $93.7M | ||
| Q2 25 | $2.0B | $78.4M | ||
| Q1 25 | $2.0B | $91.3M | ||
| Q4 24 | $2.0B | $89.2M | ||
| Q3 24 | $2.1B | $110.8M | ||
| Q2 24 | $2.3B | $116.7M | ||
| Q1 24 | $2.6B | $136.1M |
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $-7.7M |
| Free Cash FlowOCF − Capex | $14.7M | $-8.3M |
| FCF MarginFCF / Revenue | 9.9% | -88.3% |
| Capex IntensityCapex / Revenue | 4.2% | 6.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $-7.7M | ||
| Q3 25 | $2.2M | $-6.0M | ||
| Q2 25 | $25.8M | $-1.2M | ||
| Q1 25 | $14.4M | $-12.3M | ||
| Q4 24 | $29.8M | $-2.2M | ||
| Q3 24 | $17.7M | $-2.0M | ||
| Q2 24 | $9.8M | $-8.0M | ||
| Q1 24 | $8.7M | $-20.5M |
| Q4 25 | $14.7M | $-8.3M | ||
| Q3 25 | $-5.7M | $-6.3M | ||
| Q2 25 | $15.0M | $-3.0M | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $22.0M | $-2.2M | ||
| Q3 24 | $8.3M | $-2.0M | ||
| Q2 24 | $1.3M | $-8.0M | ||
| Q1 24 | $428.0K | $-20.5M |
| Q4 25 | 9.9% | -88.3% | ||
| Q3 25 | -3.6% | -46.5% | ||
| Q2 25 | 10.4% | -22.2% | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 15.0% | -17.7% | ||
| Q3 24 | 5.5% | -24.2% | ||
| Q2 24 | 0.9% | -77.1% | ||
| Q1 24 | 0.3% | -209.8% |
| Q4 25 | 4.2% | 6.4% | ||
| Q3 25 | 4.9% | 2.3% | ||
| Q2 25 | 7.5% | 13.3% | ||
| Q1 25 | 5.2% | 0.0% | ||
| Q4 24 | 5.3% | 0.2% | ||
| Q3 24 | 6.2% | 0.2% | ||
| Q2 24 | 5.9% | 0.0% | ||
| Q1 24 | 6.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -8.52× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
VELO
Segment breakdown not available.
